Products for Research Use Only
RegisterLogin

Pavurutamab

CAT: 0804-HY-P99814-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99814-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Pavurutamab (AMG-701) is a bispecific T cell engager molecule that anti-CD3 and anti-B cell maturation antigens (BCMA). Pavurutamab has an extended half-life based on Pacanalotamab. The Fc of Pavurutamab is coupled to molecules to improve pharmacokinetic parameters. Pavurutamab has potential applications in immune regulation and multiple myeloma (MM)[2][3][4].
CAS Number
2250292-39-6
Product Name Alternative
AMG-701
UNSPSC
12352203
Target
CD3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/pavurutamab.html
Purity
99.9
Solubility
10 mM in DMSO
Smiles
[Pavurutamab]
Molecular Weight
(105.78 kDa)
References & Citations
[1]Sheridan C. Bispecific antibodies poised to deliver wave of cancer therapies. Nat Biotechnol. 2021 Mar;39 (3) :251-254. |[2]Goldsmith SR, et al. Bispecific Antibodies for the Treatment of Multiple Myeloma. Curr Hematol Malig Rep. 2022 Dec;17 (6) :286-297. |[3]Cho SF, et al. The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical models. Blood Adv. 2020 Sep 8;4 (17) :4195-4207. |[4]Harrison S J, et al. A phase 1 first in human (FIH) study of AMG 701, an anti-B-cell maturation antigen (BCMA) half-life extended (HLE) BiTE® (bispecific T-cell engager) molecule, in relapsed/refractory (RR) multiple myeloma (MM) [J]. Blood, 2020, 136: 28-29.|[5]Goldstein RL, et al. AMG 701 induces cytotoxicity of multiple myeloma cells and depletes plasma cells in cynomolgus monkeys. Blood Adv. 2020 Sep 8;4 (17) :4180-4194.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
T77139-01Pavurutamab
GTR18337620-01Pavurutamab Antibody
E55B1264Pavurutamab (Reference antibody)
WA3342Research Grade Pavurutamab
21-947Pavurutamab - Research Grade Biosimilar
GTR18697407-01Pavurutamab Human Monoclonal Antibody
PX-TA1700-01Pavurutamab Biosimilar - Anti-TNFRSF17; CD3E mAb - Research Grade
A135446Pavurutamab Biosimilar (Monoclonal, (scFv-heavy-kappa) - (scFv-heavy-lambda) -scFc)

Popular Products